Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intradermal hepatitis B vaccination.

M P Rivey1, J Peterson

  • 1School of Pharmacy, University of Montana, Missoula 59812.

DICP : the Annals of Pharmacotherapy
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular stemness identifies high-risk ductal carcinoma <i>in situ</i> and offers a therapeutic interception opportunity.

bioRxiv : the preprint server for biology·2026
Same author

Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.

Physical review letters·2026
Same author

Search for Extremely-High-Energy Neutrinos and First Constraints on the Ultrahigh-Energy Cosmic-Ray Proton Fraction with IceCube.

Physical review letters·2025
Same author

Parent and perinatal professional priorities and perspectives for the pre-birth periviable conversation: a thematic analysis of semi-structured interviews.

Frontiers in pediatrics·2025
Same author

A rapid review of periviable (22 + 0 to 23 + 6 weeks) counselling practices and the need for a trauma-informed care approach.

Frontiers in pediatrics·2025
Same author

Measurement of Atmospheric Neutrino Oscillation Parameters Using Convolutional Neural Networks with 9.3 Years of Data in IceCube DeepCore.

Physical review letters·2025
Same journal

Eradication of methicillin-resistant Staphylococcus aureus vaginitis with mupirocin.

DICP : the annals of pharmacotherapy·1991
Same journal

Ketorolac formulary restriction and usage evaluation.

DICP : the annals of pharmacotherapy·1991
Same journal

Oral vancomycin-induced rash: case report and review of the literature.

DICP : the annals of pharmacotherapy·1991
Same journal

Imipenem/cilastatin drug utilization evaluation in a large community hospital.

DICP : the annals of pharmacotherapy·1991
Same journal

Pharmacist involvement in Society of Critical Care Medicine.

DICP : the annals of pharmacotherapy·1991
Same journal

Early anticoagulation therapy in deep vein thrombosis.

DICP : the annals of pharmacotherapy·1991
See all related articles

Intradermal hepatitis B virus (HBV) vaccination shows similar initial protection to intramuscular methods but may offer lower antibody levels. Further large-scale trials are needed to confirm its cost-effective potential for HBV prevention.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B virus (HBV) remains a significant global health concern despite vaccine availability since 1982.
  • Mass immunization strategies are being considered to improve HBV control.
  • Intradermal vaccination is explored as a potentially lower-cost alternative to intramuscular HBV vaccination.

Purpose of the Study:

  • To evaluate intradermal hepatitis B virus (HBV) vaccination as a cost-effective alternative to intramuscular vaccination.
  • To compare seroconversion rates and antibody responses between intradermal and intramuscular HBV vaccination routes.
  • To investigate factors influencing vaccine responsiveness to intradermal HBV vaccination.

Main Methods:

  • Open and comparative trials were conducted to assess intradermal versus intramuscular HBV vaccination in healthy adults.

Related Experiment Videos

  • Seroconversion rates were compared between the two vaccination routes.
  • Antibody titers and potential demographic influences on vaccine response were analyzed.

    • Main Results:

    • Intradermal and intramuscular HBV vaccination routes demonstrated similar seroconversion rates in healthy adults.
    • Lower antibody titers and potentially shorter duration of protection were observed with intradermal vaccination.
    • Adverse skin reactions were common but generally not prohibitive.

    Conclusions:

    • Intradermal HBV vaccination is a potential low-cost strategy, but may result in reduced antibody levels.
    • Further large-scale prospective comparative trials are essential to validate the efficacy and long-term benefits of intradermal HBV vaccination.
    • The potential economic and epidemiological advantages warrant continued investigation for HBV infection prevention.